Skip to Main Content
Upcoming Events / STAT in NYC: A Look Ahead at Biotech in 2023
  • New York, NY

STAT in NYC: A Look Ahead at Biotech in 2023

Where

Convene
237 Park Ave
New York, NY 10017

When

{{getUserDateTimeZone("1670281200").singleDate}}
{{getUserDateTimeZone("1670281200").time}} - {{getUserDateTimeZone("1670292000").time}} {{getClientTimeZoneName()}}

About

In the markets, and perhaps in the world, doom and gloom pervade. Yet science continues to move forward at a stunning pace, with big steps forward in gene editing, oncology, and neuroscience.

Come for a look at what is ahead next year, and to take the temperature of the big regulatory and financial issues facing the pharmaceutical industry — as well as for a panel featuring STAT reporters and fun, humor, and a good party.

STAT+ subscribers unlock a free ticket when they check out with their subscriber credentials!

REGISTER NOW

Agenda

6:00 PM ET – Arrival + Registration

6:30 PM ET – Opening from STAT

6:35 PM ET – Welcome Remarks Sponsor Session

Raul Damas, head of U.S. healthcare practice, Brunswick

6:40 PM ET – Preparing for an Alzheimer’s Treatment

After years of disappointment, a new medicine appears to slow the course of Alzheimer’s disease. But what do experts still need to know about?

Jason Karlawish, M.D., professor of medicine, medical ethics and health policy, and neurology; co-director, Penn Memory Center, University of Pennsylvania

Damian Garde, national biotech reporter, STAT (moderator)

7:00 PM ET – A New Era of Life Sciences Collaboration Sponsor Session

Three years of unprecedented collaboration across academia, industry, and government helped combat a global pandemic. What next?

Lloyd Minor, M.D., dean, Stanford University School of Medicine

Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)

7:10 PM ET – Eisai’s Alzheimer’s Plan

With its new Alzheimer’s drug, Eisai is fulfilling a promise it made decades ago. A discussion with the company’s leader about the hurdles and opportunities ahead.

Ivan Cheung, chairman & CEO of Eisai Inc., global Alzheimer’s disease officer, and senior corporate officer, Eisai Co., Ltd.

Jason Mast, general assignment reporter, STAT (moderator)

7:35 PM ET – Innovation, Drug Pricing, and Drinks

Come hear STAT reporters reflect on this year’s biggest newsmakers and share what they’ve got their eyes on for 2023.

Allison DeAngelis, biotech startups and venture capital reporter, STAT

Damian Garde, national biotech reporter, STAT

Jason Mast, general assignment reporter, STAT

Ed Silverman, Pharmalot columnist, senior writer, STAT

Nicholas St. Fleur, general assignment reporter; associate editorial director of events, STAT (moderator)

7:55 PM ET – Closing from STAT

8:00 PM ET – Networking Reception

 

Register Now

Host

  • STAT
  • Brunswick

More events in "Biotech"

San Francisco, CA [email protected]: What’s Next For Biotech?

It was only two years ago when it felt as if biotech had saved the world — and then, a year later, ended up in a prolonged slump. We&#